Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood

The Journal of Pediatrics
R G DluhyR P Lifton

Abstract

To review the childhood course of glucocorticoid-remediable aldosteronism (GRA) in order to provide management guidelines for hypertension in children. Records for 20 children with GRA (aged 1 month to 18 years; 16 with hypertension) were retrospectively reviewed. Of the 16 children with GRA who developed hypertension, 50% had moderate-severe hypertension (blood pressure [BP] >99th centile for age and sex); 32% had mild hypertension (BP >95th and <99th centile), and 18% had borderline normal BP (BP >90th and <95th centile). Eight of 16 children with hypertension who received directed monotherapy (glucocorticoid suppression or aldosterone receptor/sodium epithelial channel antagonists) maintained BP below the 90th centile. Three additional subjects receiving a combination of directed therapies or a combination of directed therapies and nifedipine were unable to achieve BP control. At GRA diagnosis, 5 of 8 children were normokalemic, and plasma renin activity was suppressed in 5 of 5 subjects. Clinicians should have a high index of suspicion for GRA, especially in children with severe hypertension and a positive family history of early-onset hypertension and/or premature hemorrhagic stroke. Directed monotherapy is often successfu...Continue Reading

Citations

Jul 25, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·V Matti Vehaskari
Sep 1, 2009·Journal of Clinical Research in Pediatric Endocrinology·John W Honour
Aug 27, 2009·Case Reports in Medicine·Louis Z G Touyz
Nov 21, 2008·Clinical and Experimental Hypertension : CHE·Paolo MulateroFranco Veglio
Feb 8, 2008·The Journal of Clinical Hypertension·Bruno SontiaRhian M Touyz
Jun 19, 2007·Clinical Endocrinology·Paolo MulateroFranco Veglio
Jul 2, 2016·Case Reports in Endocrinology·Anahita ShahrravaRohan Shah
Apr 6, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Melvin Bonilla-Félix
Dec 12, 2003·Cardiology in Review·Graham T McMahon, Robert G Dluhy
Dec 12, 2012·Nature Reviews. Endocrinology·Paolo MulateroTracy Ann Williams
Feb 4, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Michael Freundlich, Michael Ludwig
Aug 4, 2006·Current Hypertension Reports·Maciej TomaszewskiAnna F Dominiczak
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Jason L AdlerCraig B Langman
Sep 6, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yasuyuki KatayamaHironobu Sasano
Jun 17, 2008·The Journal of Clinical Endocrinology and Metabolism·John W FunderUNKNOWN Endocrine Society
Dec 24, 2019·Cardiology in Review·Padma Raghavan PillaiIrene A Weiss
May 1, 2002·Current Opinion in Pediatrics·Umbereen S Nehal, Julie R Ingelfinger
May 6, 2004·Journal of Hypertension·Paolo MulateroFranco Veglio
May 31, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ian Macumber, Joseph T Flynn
Mar 5, 2016·The Journal of Clinical Endocrinology and Metabolism·John W FunderWilliam F Young
Mar 12, 2005·Arquivos brasileiros de endocrinologia e metabologia·Graham T McMahon, Robert G Dluhy
Dec 13, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Bar Rotem-Grunbaum, Daniel Landau
May 23, 2002·American Journal of Hypertension·George A MansoorGiles F Whalen
Jul 13, 2017·Archives of Endocrinology and Metabolism·Leticia A P Vilela, Madson Q Almeida
Mar 2, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yasuhiro NakanoFumio Otsuka
Oct 10, 2006·Pediatric Clinics of North America·Julie R Ingelfinger
Feb 6, 2007·Seminars in Nephrology·Gema Ariceta, Juan Rodríguez-Soriano
Aug 21, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Priyanka Khandelwal, Jaap Deinum
Jul 24, 2007·The Journal of Pediatrics·Kevin FriedmanMelissa A Cadnapaphornchai
Sep 1, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Xiaoning LiuJun Cai
Nov 14, 2020·Current Pharmaceutical Design·Eleni P KotanidouAssimina Galli-Tsinopoulou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

Critical Reviews in Clinical Laboratory Sciences
Decio ArmaniniAndrea Semplicini
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
J-E Dewez, A Bachy
© 2021 Meta ULC. All rights reserved